Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
APO-FLUOXETINE | APOTEX INC | Anticipated shortage | 20MG | New Report | 2024-12-11 | 245462 |
APO-FLUOXETINE | APOTEX INC | Anticipated shortage | 20MG | New Report | 2024-12-11 | 245459 |
APO-FLUOXETINE | APOTEX INC | Anticipated shortage | 10MG | New Report | 2024-12-11 | 245456 |
BEYFORTUS | SANOFI PASTEUR LIMITED | Anticipated shortage | 100MG | Updated Report | 2024-12-11 | 245452 |
AVENTYL | AA PHARMA INC | Actual shortage | 10MG | Updated Report | 2024-12-11 | 245448 |
MINOCYCLINE | AA PHARMA INC | Actual shortage | 50MG | New Report | 2024-12-11 | 245445 |
ELAVIL | AA PHARMA INC | Actual shortage | 50MG | New Report | 2024-12-11 | 245442 |
METHOPRAZINE | AA PHARMA INC | Actual shortage | 25MG | Updated Report | 2024-12-11 | 242915 |
ENALAPRIL MALEATE/HCTZ | AA PHARMA INC | Resolved | 25MG 10MG | Updated Report | 2024-12-11 | 242184 |
MEFENAMIC | AA PHARMA INC | Resolved | 250MG | Updated Report | 2024-12-11 | 240624 |
5% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 5G | Updated Report | 2024-12-11 | 234262 |
0.9% SODIUM CHLORIDE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 900MG | Updated Report | 2024-12-11 | 234265 |
DOCUSATE SODIUM | PRO DOC LIMITEE | Actual shortage | 100MG | Updated Report | 2024-12-11 | 241984 |
INDOCYANINE GREEN FOR INJECTION, USP | DIAGNOSTIC GREEN LIMITED | Actual shortage | 25MG | Updated Report | 2024-12-11 | 234081 |
LMD 10% IN 0.9% SODIUM CHLORIDE | PFIZER CANADA ULC | Actual shortage | 0.9% 10% | Updated Report | 2024-12-11 | 239954 |
ORILISSA | ABBVIE CORPORATION | Anticipated shortage | 200MG | Updated Report | 2024-12-11 | 245420 |
WELLBUTRIN XL | BAUSCH HEALTH, CANADA INC. | Actual shortage | 150MG | Updated Report | 2024-12-11 | 244139 |
RETIN-A | BAUSCH HEALTH, CANADA INC. | Actual shortage | 0.025% | Updated Report | 2024-12-11 | 244980 |
RETROVIR (AZT) | VIIV HEALTHCARE ULC | Resolved | 50MG | Updated Report | 2024-12-11 | 244220 |
M-MONTELUKAST | MANTRA PHARMA INC | Actual shortage | 10MG | New Report | 2024-12-11 | 245411 |
M-LATANOPROST-TIMOLOL | MANTRA PHARMA INC | Actual shortage | 5MG 50MCG | New Report | 2024-12-11 | 245408 |
M-LATANOPROST | MANTRA PHARMA INC | Actual shortage | 50MCG | New Report | 2024-12-11 | 245405 |
M-LANSOPRAZOLE | MANTRA PHARMA INC | Actual shortage | 30MG | New Report | 2024-12-11 | 245402 |
M-LANSOPRAZOLE | MANTRA PHARMA INC | Actual shortage | 15MG | New Report | 2024-12-11 | 245399 |
M-BETAHISTINE | MANTRA PHARMA INC | Actual shortage | 24MG | New Report | 2024-12-11 | 245396 |
M-BETAHISTINE | MANTRA PHARMA INC | Actual shortage | 16MG | New Report | 2024-12-11 | 245393 |
M-BETAHISTINE | MANTRA PHARMA INC | Actual shortage | 8MG | New Report | 2024-12-11 | 245390 |
M-AZITHROMYCIN | MANTRA PHARMA INC | Actual shortage | 250MG | New Report | 2024-12-11 | 245387 |
M-AZITHROMYCIN | MANTRA PHARMA INC | Actual shortage | 250MG | New Report | 2024-12-11 | 245384 |
M-LEVETIRACETAM | MANTRA PHARMA INC | Actual shortage | 500MG | New Report | 2024-12-11 | 225527 |
M-LEVETIRACETAM | MANTRA PHARMA INC | Actual shortage | 750MG | New Report | 2024-12-11 | 225536 |
M-PRAVASTATIN | MANTRA PHARMA INC | Actual shortage | 20MG | Updated Report | 2024-12-11 | 225548 |
M-PRAVASTATIN | MANTRA PHARMA INC | Actual shortage | 40MG | Updated Report | 2024-12-11 | 225556 |
M-SOLIFENACIN SUCCINATE | MANTRA PHARMA INC | Actual shortage | 5MG | New Report | 2024-12-11 | 225565 |
M-SOLIFENACIN SUCCINATE | MANTRA PHARMA INC | Actual shortage | 10MG | New Report | 2024-12-11 | 225571 |
M-QUETIAPINE FUMARATE XR | MANTRA PHARMA INC | Actual shortage | 150MG | New Report | 2024-12-11 | 233180 |
M-QUETIAPINE FUMARATE XR | MANTRA PHARMA INC | Actual shortage | 200MG | New Report | 2024-12-11 | 233183 |
M-QUETIAPINE FUMARATE XR | MANTRA PHARMA INC | Actual shortage | 300MG | New Report | 2024-12-11 | 233186 |
M-QUETIAPINE FUMARATE XR | MANTRA PHARMA INC | Actual shortage | 400MG | New Report | 2024-12-11 | 233189 |
ORILISSA | ABBVIE CORPORATION | Anticipated shortage | 150MG | Updated Report | 2024-12-11 | 245357 |
PMS-CHLORHEXIDINE WITHOUT ALCOHOL | PHARMASCIENCE INC | Actual shortage | 0.12% | Updated Report | 2024-12-11 | 211878 |
RIZATRIPTAN | SANIS HEALTH INC | Actual shortage | 10MG | Updated Report | 2024-12-11 | 240737 |
MOXIFLOXACIN | SANIS HEALTH INC | Actual shortage | 400MG | Updated Report | 2024-12-11 | 228981 |
LOSARTAN/HCTZ | SANIS HEALTH INC | Actual shortage | 25MG 100MG | Updated Report | 2024-12-11 | 235045 |
CANDESARTAN/HCTZ | SANIS HEALTH INC | Actual shortage | 12.5MG 16MG | Updated Report | 2024-12-11 | 240722 |
TOBRAMYCIN FOR INJECTION | FRESENIUS KABI CANADA LTD | Actual shortage | 1.2G | Updated Report | 2024-12-11 | 245141 |
SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Resolved | 1.5MG | Updated Report | 2024-12-11 | 230768 |
SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Resolved | 4.5MG | Updated Report | 2024-12-11 | 234493 |
SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Resolved | 1.5MG | Updated Report | 2024-12-11 | 235071 |
SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Resolved | 6MG | Updated Report | 2024-12-11 | 235570 |